Fruzsina Mezei | Nursing and Health Professions | Innovative Research Award

Published on by Invention Awards

Innovative Research Award

Fruzsina Mezei
Università Cattolica del Sacro Cuore
Fruzsina Mezei
Affiliation Università Cattolica del Sacro Cuore
Country Italy
Scopus ID 57225091697
Documents 8
Citations 65
h-index 3
Google Scholar JlzScJMAAAAJ&hl
Subject Area Nursing and Health Professions
Event International Invention Awards
ORCID 0000-0001-5924-9781

Fruzsina Mezei is a researcher affiliated with Università Cattolica del Sacro Cuore whose scholarly activities contribute to nursing and health professions research through evidence-based investigation and interdisciplinary collaboration. Her published studies demonstrate engagement with healthcare improvement, scientific methodology, and clinical knowledge development. Indexed academic outputs and measurable citation indicators reflect the visibility of her work within international databases, supporting recognition for sustained contributions to healthcare research and innovation.[1]

Abstract

Fruzsina Mezei has established a developing academic profile within nursing and health professions through research emphasizing evidence-based practice, healthcare quality, and interdisciplinary collaboration. Her indexed publications contribute to scientific understanding by addressing clinically relevant questions and supporting informed healthcare decision-making. Bibliometric indicators demonstrate growing scholarly visibility, while citation performance reflects recognition by the wider research community. Through collaboration with healthcare researchers and institutions, her work promotes methodological rigor, knowledge dissemination, and practical application. These characteristics collectively illustrate an active research trajectory appropriate for academic recognition within international innovation and research award programs.[2]

Keywords

Nursing Research, Health Professions, Clinical Research, Evidence-Based Practice, Healthcare Innovation, Scientific Collaboration, Medical Education, Patient Care, Healthcare Quality, Research Impact.

Introduction

Academic research within nursing and health professions plays an essential role in advancing healthcare quality and improving patient outcomes through systematic investigation. Fruzsina Mezei contributes to this objective by participating in scholarly research that supports evidence generation, encourages interdisciplinary cooperation, and strengthens scientific understanding within healthcare environments while maintaining alignment with internationally recognized research standards.[3]

Research Profile

The research profile of Fruzsina Mezei reflects continued scholarly activity documented within Scopus and supported by measurable publication and citation metrics. Her affiliation with Università Cattolica del Sacro Cuore provides an environment encouraging multidisciplinary collaboration, academic excellence, and meaningful healthcare research addressing clinically relevant challenges across nursing and health professions.[1]

Research Contributions

Her scientific contributions emphasize rigorous investigation, collaborative publication, and dissemination of healthcare knowledge through peer-reviewed research. These studies contribute to understanding healthcare practice, clinical outcomes, and evidence-based approaches while supporting future investigations. Such contributions strengthen academic dialogue and encourage continuous improvements within nursing and related healthcare disciplines internationally.[4]

Publications

The documented publication record includes peer-reviewed journal articles indexed within Scopus, demonstrating consistent engagement with healthcare research. These publications collectively represent scientific productivity and collaboration while contributing evidence to professional literature. Their accessibility through international indexing services enhances discoverability, supports citation growth, and promotes broader academic communication across healthcare research communities.[1]

Research Impact

Research impact may be observed through publication visibility, citation performance, and scholarly engagement within international databases. The available bibliometric indicators demonstrate that Fruzsina Mezei’s work has attracted academic attention and contributes to ongoing scientific discussions. Such measurable outcomes indicate meaningful participation in healthcare research while supporting future collaborative opportunities and continued scientific development.[2]

Award Suitability

Considering documented scholarly productivity, international indexing, measurable citation indicators, and contributions to nursing and health professions, Fruzsina Mezei demonstrates characteristics commonly associated with candidates for research recognition. Her sustained academic engagement, commitment to evidence-based investigation, and collaborative scientific output align appropriately with the objectives of the International Invention Awards and similar research excellence programs.[5]

Conclusion

Fruzsina Mezei maintains a growing academic profile supported by indexed publications, scholarly citations, and interdisciplinary healthcare research. Her documented achievements illustrate meaningful scientific participation and demonstrate continued commitment to advancing nursing and health professions through evidence-based inquiry, making her research profile suitable for professional academic recognition and international visibility.[2]

References

  1. Elsevier. (n.d.). Scopus Author Details: Fruzsina Mezei, Author ID 57225091697.
    https://www.scopus.com/pages/authors/57225091697
  2. ORCID. (n.d.). Fruzsina Mezei ORCID Record.
    https://orcid.org/0000-0001-5924-9781
  3. Journal article. (2022.). Digitális egészségügyi technológiák értékelése – Diabétesz applikációk Németországban.
    https://doi.org/10.53020/IME-2022-207
  4. Journal article. (2021.). Countrywide survey on utilization of medical devices by GPs in Hungary: advantages of the cluster-practice model.
    https://doi.org/10.1017/s1463423621000372
  5. International Invention Awards. (2026.). Official Award Website.
    https://inventionawards.org/

Hamidreza Ghasemirad | Medicine and Dentistry | Young Researcher Award

Published on by Invention Awards

Young Researcher Award

Hamidreza Ghasemirad
Affiliation Shahid Sadoughi University of Medical Sciences, Yazd
Country Iran
Scopus ID 57720329700
Documents 15
Citations 121
h-index 6
Subject Area Medicine and Dentistry
Event International Invention Awards
ORCID 0000-0002-5390-6653

Hamidreza Ghasemirad

Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Hamidreza Ghasemirad is an emerging researcher affiliated with Shahid Sadoughi University of Medical Sciences, Yazd, whose scholarly activities primarily focus on medicine and dentistry. His publication record, citation performance, and measurable research impact demonstrate consistent academic development during the early stages of his career. These achievements indicate sustained engagement in evidence-based research and interdisciplinary collaboration while contributing to scientific knowledge within healthcare-related disciplines.[1]

Abstract

Hamidreza Ghasemirad has established a developing academic profile through research activities in medicine and dentistry, supported by peer-reviewed publications and measurable citation performance. His scholarly work reflects an emphasis on scientific rigor, collaborative investigation, and evidence-based healthcare research. With fifteen indexed documents, one hundred twenty-one citations, and an h-index of six, his contributions indicate growing recognition within the research community. These accomplishments demonstrate continued engagement with contemporary medical challenges while highlighting the potential for future innovation, interdisciplinary collaboration, and broader international scientific influence through sustained publication and research excellence.[1][2]

Keywords

Medicine, Dentistry, Clinical Research, Healthcare Innovation, Scientific Publications, Citation Impact, Early Career Researcher, Medical Sciences.

Introduction

The advancement of medical science depends on researchers capable of generating reliable evidence while addressing emerging healthcare challenges. Early-career scholars play a significant role by introducing innovative perspectives and expanding interdisciplinary collaboration. Hamidreza Ghasemirad represents this developing generation of researchers through consistent scientific productivity and participation in internationally indexed research activities that contribute to academic progress.[2]

Research Profile

Affiliated with Shahid Sadoughi University of Medical Sciences, Yazd, Hamidreza Ghasemirad has developed a research portfolio centered on medicine and dentistry. His scholarly record demonstrates active participation in peer-reviewed publishing, with research recognized through citations and indexing in international bibliographic databases. These indicators reflect an expanding academic presence and commitment to maintaining recognized standards of scientific quality.[1]

Research Contributions

His research contributions encompass scientific investigations that support evidence-based healthcare and clinical understanding. Through collaborative publications and analytical research methods, he has participated in studies that strengthen medical knowledge while encouraging practical application within healthcare settings. The cumulative influence of these publications demonstrates meaningful engagement with contemporary scientific questions and ongoing academic development.[3]

Publications

The available publication record includes fifteen Scopus-indexed documents spanning medical and dental sciences. These publications reflect participation in peer-reviewed scholarly communication and illustrate a sustained commitment to disseminating research findings through internationally recognized academic platforms. Citation accumulation further indicates that the published work has received attention from researchers working in related scientific disciplines.[1][4]

Research Impact

Research impact is commonly evaluated using citation metrics, publication quality, scholarly visibility, and sustained contribution to scientific advancement. Hamidreza Ghasemirad’s citation record and h-index demonstrate that his work has achieved measurable recognition within the academic community. These indicators suggest continuing influence and provide a foundation for future collaborative and interdisciplinary research opportunities.[2]

Award Suitability

Based on documented publication output, citation performance, and active engagement in medical research, Hamidreza Ghasemirad demonstrates characteristics commonly associated with emerging scientific leadership. His growing academic profile, commitment to peer-reviewed scholarship, and measurable research visibility align well with the objectives of the Young Researcher Award presented during the International Invention Awards, where recognition emphasizes promising scientific achievement and future research potential.[5]

Conclusion

Hamidreza Ghasemirad has established a developing academic profile through consistent scholarly activity in medicine and dentistry. His publication record, citation performance, and institutional affiliation collectively indicate sustained research engagement and continuing professional growth. These achievements provide a strong foundation for future scientific contributions while supporting consideration for academic recognition through international research award programs.[1]

External Links

References

  1. Elsevier. (n.d.). Scopus Author Details: Hamidreza Ghasemirad, Author ID 57720329700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57720329700
  2. ORCID. (n.d.). ORCID Record: Hamidreza Ghasemirad.
    https://orcid.org/0000-0002-5390-6653
  3. Pharmaceutical and Biomedical Research. (2025). Clinical and Prognostic Findings in Psychotropic Substance Poisoning: A Cross-sectional Study.
    https://doi.org/10.32598/pbr.11.3.1366.1
  4. Molecular and Cellular Biochemistry. (2023). The circadian clock as a potential biomarker and therapeutic target in pancreatic cancer.
    https://doi.org/10.1007/s11010-023-04790-4
  5. International Invention Awards. (n.d.). Award Information and Recognition Program.
    https://inventionawards.org/

Leticia Szadai | Medicine and Dentistry | Best Researcher Award

Published on by Invention Awards

Best Researcher Award

Leticia Szadai
Lund University, Sweden

Leticia Szadai
Affiliation Lund University
Country Sweden
Google Scholar ID CNcrXOIAAAAJ
Documents 27
Citations 175
h-index 7
Subject Area Medicine and Dentistry
Event International Invention Awards

The Best Researcher Award recognizes researchers whose scholarly activities have contributed to the advancement of knowledge and innovation within their respective disciplines. Leticia Szadai of Lund University has developed a research profile centered on melanoma biology, proteomics, biomarker discovery, and translational cancer research. Her work integrates advanced molecular analysis with clinical applications, supporting improved understanding of melanoma progression, recurrence mechanisms, and therapeutic opportunities. Through collaborative research efforts, she has contributed to the generation of valuable datasets and analytical frameworks relevant to modern oncology research.[1]

Abstract

This article summarizes the academic achievements and research contributions of Leticia Szadai. Her work primarily focuses on melanoma proteomics, molecular pathology, biomarker identification, and translational oncology. Through participation in multidisciplinary investigations, she has contributed to the development of proteomic resources and analytical methods that support precision medicine approaches in cancer research.[2]

Keywords

Melanoma, Proteomics, Molecular Pathology, Biomarkers, Translational Medicine, Cancer Research, Precision Oncology, Tumor Biology.

Introduction

Advances in cancer research increasingly depend on interdisciplinary methodologies that connect molecular science with clinical practice. Leticia Szadai has contributed to this field through studies examining melanoma biology and the molecular factors associated with disease progression and recurrence. Her research reflects contemporary efforts to improve diagnostic and prognostic strategies through large-scale proteomic investigation.[3]

Research Profile

As a researcher affiliated with Lund University, Leticia Szadai has participated in projects involving molecular oncology, clinical proteomics, and translational medicine. Her publication record demonstrates engagement with collaborative international research initiatives focused on melanoma tissue analysis, mitochondrial regulation, immune response mechanisms, and biomarker discovery. These efforts contribute to the broader objective of enhancing evidence-based cancer management.[4]

Research Contributions

  • Contributed to studies establishing comprehensive melanoma proteome atlases.
  • Investigated molecular pathology and protein expression patterns in melanoma.
  • Explored mitochondrial dysfunction and immune response dysregulation associated with melanoma recurrence.
  • Participated in biomarker discovery using archived tumor samples and advanced proteomic technologies.
  • Supported research into kinase signaling pathways and translational applications in oncology.

Publications

  • The Human Melanoma Proteome Atlas—Complementing the Melanoma Transcriptome (2021).
  • The Human Melanoma Proteome Atlas—Defining the Molecular Pathology (2021).
  • Mitochondrial and Immune Response Dysregulation in Melanoma Recurrence (2023).
  • Deep Proteomic Analysis on Biobanked Paraffin-Archived Melanoma with Prognostic/Predictive Biomarker Read-Out (2021).
  • A Biobanking Turning-Point in the Use of Formalin-Fixed, Paraffin Tumor Blocks to Unveil Kinase Signaling in Melanoma (2021).

Research Impact

The available citation metrics indicate that Leticia Szadai’s research outputs have attracted scholarly attention within oncology and translational medicine communities. Her involvement in high-impact collaborative studies has supported the development of proteomic resources that facilitate future investigations into melanoma progression, biomarker validation, and personalized therapeutic strategies. These contributions demonstrate measurable academic influence and continuing relevance to cancer research.[5]

Award Suitability

Leticia Szadai’s research portfolio aligns with the objectives of the International Invention Awards and the Best Researcher Award category. Her scholarly contributions reflect innovation in proteomic methodology, translational cancer research, and biomarker development. The combination of publication activity, collaborative leadership, and clinically relevant outcomes supports recognition for contributions to medicine and dentistry-related scientific advancement.[6]

Conclusion

Leticia Szadai has established a research profile characterized by rigorous investigation of melanoma biology and proteomics. Her contributions to translational oncology, biomarker discovery, and molecular pathology have supported scientific understanding of cancer mechanisms and potential clinical applications. These achievements provide a strong foundation for academic recognition through the Best Researcher Award.

References

  1. Elsevier. (n.d.). Google Scholar author details: Leticia Szadai
    https://scholar.google.com/citations?hl=hu&user=CNcrXOIAAAAJ
  2. Betancourt LH et al. (2021). The Human Melanoma Proteome Atlas—Complementing the Melanoma Transcriptome. Clinical and Translational Medicine.
    https://doi.org/10.1002/ctm2.451
  3. Betancourt LH et al. (2021). The Human Melanoma Proteome Atlas—Defining the Molecular Pathology. Clinical and Translational Medicine.
    https://doi.org/10.1002/ctm2.473
  4. Szadai L et al. (2023). Mitochondrial and Immune Response Dysregulation in Melanoma Recurrence. Clinical and Translational Medicine.
    https://doi.org/10.1002/ctm2.1495
  5. Szadai L et al. (2021). Deep Proteomic Analysis on Biobanked Paraffin-Archived Melanoma with Prognostic/Predictive Biomarker Read-Out. Cancers.
    https://doi.org/10.3390/cancers13236105
  6. Velasquez E et al. (2021). A Biobanking Turning-Point in the Use of Formalin-Fixed, Paraffin Tumor Blocks to Unveil Kinase Signaling in Melanoma. Clinical and Translational Medicine.
    https://doi.org/10.1002/ctm2.466

A. Marcell Szasz | Medicine and Dentistry | Excellence in Research Award

Published on by Invention Awards

Excellence in Research Award

A. Marcell Szasz
Semmelweis University, Hungary

A. Marcell Szasz
Affiliation Semmelweis University
Country Hungary
Scopus ID 24723204500
Documents 147
Citations 4,107
h-index 29
Subject Area Medicine and Dentistry
Event International Invention Awards
Google Scholar ID eeJzLNQAAAAJ

The Excellence in Research Award recognizes researchers whose scholarly activities demonstrate sustained contributions to scientific advancement, interdisciplinary collaboration, and measurable research impact. A. Marcell Szasz of Semmelweis University has developed a notable academic profile in medicine and cancer research through influential publications, biomarker studies, translational oncology investigations, and evidence-based clinical analyses.[1] His publication record and citation performance indicate significant engagement within the international scientific community.[2]

Abstract

A. Marcell Szasz has contributed to the fields of oncology, molecular medicine, prognostic biomarker analysis, and cancer outcome prediction. His research portfolio encompasses gene-expression studies, clinical meta-analyses, cancer progression modeling, and translational medical investigations. Through collaborations with international research teams, his work has informed understanding of disease mechanisms and patient stratification approaches in modern oncology.[2]

Keywords

Oncology, Biomarkers, Precision Medicine, Cancer Research, Meta-analysis, Gene Expression, Translational Medicine, Clinical Research.

Introduction

Research excellence is frequently evaluated through scientific influence, publication quality, citation impact, and contribution to knowledge development. Within this context, A. Marcell Szasz has established a scholarly presence through studies addressing cancer biology, prognostic biomarkers, and therapeutic outcomes. His work contributes to evidence-based approaches used in clinical and translational medicine.[3]

Research Profile

The researcher maintains a substantial publication portfolio consisting of 147 indexed documents, more than 4,100 citations, and an h-index of 29. His academic activity is primarily associated with medicine, oncology, pathology, molecular diagnostics, and clinical outcome assessment. These metrics reflect both productivity and sustained visibility within international scientific literature.[1]

Research Contributions

  • Investigation of microRNA regulation and metastatic progression in breast cancer.
  • Development and validation of transcriptomic biomarkers associated with survival outcomes.
  • Comprehensive meta-analyses supporting clinical decision-making in oncology.
  • Studies examining genomic alterations and evolutionary pathways of metastatic disease.

Publications

Among his most cited publications are studies on miR-31 and breast cancer metastasis, transcriptomic biomarker validation in gastric cancer, urachal carcinoma meta-analysis, tamoxifen-response biomarkers, and phylogenetic analyses of metastatic progression.[4] These works have received substantial scholarly attention and have been referenced extensively in subsequent research.

Research Impact

The citation performance associated with A. Marcell Szasz demonstrates broad engagement from researchers across oncology, pathology, molecular biology, and clinical medicine. His publications have contributed to methodological refinement, biomarker validation, and evidence synthesis efforts that support future investigations and clinical translation.[5]

Award Suitability

The Excellence in Research Award emphasizes scientific rigor, research influence, and sustained scholarly contribution. Based on publication metrics, citation impact, interdisciplinary collaborations, and documented contributions to cancer research, A. Marcell Szasz demonstrates characteristics commonly associated with distinguished academic achievement and research leadership.[6]

Conclusion

A. Marcell Szasz has contributed meaningfully to contemporary oncology research through studies addressing biomarkers, disease progression, and clinical outcomes. His publication record, citation profile, and participation in influential collaborative projects provide a strong foundation for recognition within an academic award framework focused on research excellence.

References

  1. Elsevier. (n.d.). Scopus author details: A. Marcell Szasz, Author ID 24723204500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=24723204500
  2. Valastyan S., Reinhardt F., et al. (2009). miR-31 inhibits breast cancer metastasis. Cell.
    DOI: https://doi.org/10.1016/j.cell.2009.03.047
  3. Szász A.M., Lánczky A., et al. (2016). Cross-validation of survival associated biomarkers in gastric cancer. Oncotarget.
    DOI: https://doi.org/10.18632/oncotarget.10337
  4. Brown D., Smeets D., Székely B., Szasz A.M., et al. (2017). Phylogenetic analysis of metastatic progression in breast cancer. Nature Communications.
    DOI: https://doi.org/10.1038/ncomms14944
  5. Mihály Z., Kormos M., Lánczky A., et al. (2013). Gene expression-based biomarkers predicting outcome after tamoxifen treatment.
    DOI: https://doi.org/10.1007/s10549-013-2619-y
  6. Szarvas T., Módos O., Niedworok C., et al. (2016). Clinical, prognostic, and therapeutic aspects of urachal carcinoma.
    DOI: https://doi.org/10.1016/j.urolonc.2016.04.012

Gaia Cattador | Medicine and Dentistry | Research Excellence Award

Published on by Invention Awards

Dr. Gaia Cattador | Medicine and Dentistry | Research Excellence Award

Cardiologist in Multimedical, Italy

Dr. Gaia Cattadori is a highly accomplished cardiologist with an extensive academic, clinical, and research career in cardiovascular medicine. She earned her medical degree with top honors and completed her specialization in cardiology, followed by national academic qualification as an associate professor in cardiovascular and respiratory diseases. She has held long-standing teaching roles in medical and healthcare programs, mentoring students and contributing to professional training across multiple academic levels. Her clinical career includes leadership positions in cardiac rehabilitation and heart failure units, with deep expertise in cardiopulmonary exercise testing and cardiovascular physiology. She has been actively involved in numerous national and international research projects, often serving as principal or co-investigator, focusing on heart failure, rehabilitation, and cardiopulmonary function. She has coordinated and participated in multidisciplinary and multicenter research networks, contributing to advancements in clinical cardiology. Her work also includes organizing and leading research groups and registries, particularly in heart failure and elderly patient care. She has been a frequent speaker and organizer at major scientific conferences, presenting on topics such as cardiac rehabilitation, heart failure management, and exercise physiology. Her contributions extend to collaborative international studies and clinical trials aimed at improving patient outcomes. In recognition of her academic excellence and research contributions, she has received prestigious awards for young researchers and professional merit.

Citation Metrics (Scopus)

4000
3500
3000
2500
2000
1500
1000
500
100
0

Citations
3582

Documents
109

h-index
36

Citations

Documents

h-index

View Scopus Profile

Featured Publications

 

Bozena Futoma-Koloch | Immunology and Microbiology | Best Faculty Award

Published on by Invention Awards

Dr. Bozena Futoma-Koloch | Immunology and Microbiology | Best Faculty Award 

University of Wroclaw | Poland

Dr. Bożena Futoma-Kołoch is an accomplished microbiologist whose research integrates microbial pathogenesis, antimicrobial resistance, and host–pathogen interactions, with a particular focus on Salmonella enterica. She is an Assistant Professor in the Department of Microbiology at the University of Wrocław, where she has built a coherent and internationally recognized research program grounded in molecular microbiology, immunology, and environmental microbiology. Her scientific work has substantially advanced understanding of how environmental stressors especially disinfectants, antiseptics, and human serum—shape bacterial virulence and survival. A central theme of her research is the phenomenon of cross-resistance, whereby exposure to biocides influences bacterial tolerance to antibiotics and serum-mediated immune defenses. Through detailed phenotypic and proteomic analyses, Dr. Futoma-Kołoch has demonstrated that changes in outer membrane proteins (OMPs) play a pivotal role in mediating resistance to serum complement, antibiotics, and disinfectants. These findings have provided new mechanistic insights into bacterial adaptation and have identified OMPs as promising biomarkers and potential therapeutic targets in the fight against multidrug-resistant pathogens. Her habilitation work, “Effect of disinfectants and serum on the phenotype associated with virulence in non-typhoid Salmonella enterica strains” (2024), represents a significant milestone, consolidating years of systematic research into how chemical and immunological pressures modulate virulence-associated traits. This research has strong translational relevance for public health, food safety, and infection control, particularly in the context of increasing antimicrobial resistance and widespread biocide use. Dr. Futoma-Kołoch is also actively engaged in interdisciplinary and applied research. Dr. Futoma-Kołoch’s scholarly output includes influential review articles that are widely cited and shape current thinking on bacterial virulence, serum resistance, and antimicrobial defense mechanisms. Her leadership in international collaborations, participation in COST Actions, and service as an editor and reviewer for high-impact journals further attest to her standing in the global microbiology community. Overall, her research profile reflects originality, continuity, and significant impact on both basic science and applied infectious disease research.

Citation Metrics (Google Scholar)

500
400
300
200
100
0

Citations
407

i10index
30

h-index
12

Citations

i10-index

h-index

View Google Scholar Profile

Featured Publications


Biological activity of quaternary ammonium salts and resistance of microorganisms to these compounds

– World Journal of Microbiology and Biotechnology, 2021 | Cited by: 57

 

Nicola Cosentino | Medicine and Dentistry | Breakthrough Research Award

Published on by Invention Awards

Dr. Nicola Cosentino | Medicine and Dentistry | Breakthrough Research Award

Dr. Nicola Cosentino | Centro Cardiologioco Monzino | Italy

Dr. Nicola Cosentino is a distinguished Italian cardiologist and researcher whose clinical and scientific contributions have significantly advanced the field of cardiovascular medicine. His career reflects a seamless integration of clinical excellence, research innovation, and academic leadership. With extensive expertise in acute coronary syndromes, perioperative cardiology, and intensive cardiac care, Dr. Cosentino has demonstrated a lifelong commitment to improving patient care through evidence-based medicine and cutting-edge research. His dedication is further underscored by his leadership roles within leading medical institutions and international collaborations, which have allowed him to shape both clinical practice and future research directions. Through a holistic approach that combines patient care, translational science, and teaching, Dr. Cosentino stands as a leading figure in cardiology whose work continues to impact patients, students, and the global medical community. His professional journey represents excellence, perseverance, and innovation in cardiovascular healthcare.

Profiles

Scopus
Orcid

Education

Dr. Nicola Cosentino reflects a trajectory of distinction and excellence in the medical sciences. His educational journey began with a diploma from the Classical High School in Italy, where he graduated with the highest honors, demonstrating early intellectual rigor and dedication. He subsequently earned his medical degree from the Sacred Heart Catholic University of Rome, graduating with full honors and recognition for his thesis on eosinophils in coronary atherosclerosis, conducted under the mentorship of world-renowned cardiology experts. He further specialized in cardiology with distinction at the same institution, completing his specialization with highest marks for a thesis on monocyte-derived macrophages in ischemic heart disease. To deepen his scientific expertise, Dr. Cosentino pursued a PhD in Translational Medicine at the University of Milan, consolidating his commitment to bridging laboratory science with clinical practice. His comprehensive educational training represents a balanced blend of clinical mastery and research excellence.

Experience

Dr. Nicola Cosentino has established an outstanding career marked by diverse clinical and leadership roles within some of Italy’s most prestigious medical institutions. His early professional development was shaped at the Centro Cardiologico Monzino, Milan, where he developed a strong clinical foundation in managing acute and chronic ischemic heart diseases, as well as high-risk cardiovascular conditions. Over the years, he has progressed through key roles, including staff cardiologist, head of the Acute Coronary Syndrome Unit, and medical lead manager of the Italian cardiovascular team at AstraZeneca. Most recently, he was appointed head of the Peri-Operative Cardiology Unit at Centro Cardiologico Monzino, where he now leads advanced clinical programs integrating perioperative assessment, risk management, and innovative therapeutic strategies. His professional journey combines patient care, organizational leadership, and scientific guidance, demonstrating a career that consistently bridges cutting-edge cardiology with practical, patient-centered applications in both hospital and industry settings.

Research Interest

Dr. Cosentino are centered on understanding and addressing the mechanisms underlying coronary artery disease and heart failure, both in acute and chronic presentations. His work has focused extensively on identifying novel biomarkers and molecular pathways that influence the diagnosis, prognosis, and management of these conditions. Special emphasis has been placed on investigating the role of diabetes mellitus, renal impairment, and multi-organ involvement in cardiovascular disease progression. His research also explores the clinical significance of myocardial remodeling and inflammation in acute coronary syndromes, as well as the role of advanced cardiovascular monitoring technologies. By integrating molecular science with patient-focused clinical research, Dr. Cosentino continues to contribute valuable insights into translational cardiology. His long-standing dedication has positioned him as a leading voice in precision medicine approaches, aiming to personalize treatment strategies and improve outcomes for patients facing life-threatening cardiovascular events.

Awards & Recognitions

Dr. Cosentino’s research achievements is reflected in his numerous awards and competitive research grants. His early career excellence was acknowledged through support from the Fondazione Umberto Veronesi, funding projects that examined monocyte-derived macrophages and coronary plaque morphology in ischemic heart disease. He was further awarded competitive grants from the Italian Ministry of Health, including the prestigious “Giovani Ricercatori” program for his PROMISE study on myocardial infarction and non-obstructive coronary arteries, and later through a national PNRR project exploring mitochondrial targets for stroke treatment. These recognitions highlight the innovative and impactful nature of his work, aligning with global efforts to improve cardiovascular diagnostics and therapy. Beyond financial grants, he has been entrusted with leadership positions in scientific societies and advisory committees, reflecting confidence in his scientific judgment. Collectively, these awards affirm his role as a rising leader whose contributions hold significant promise for the future of cardiovascular medicine.

Publication Top Notes

Prognostic Impact of Percutaneous Coronary Intervention in Older Patients Hospitalized with Acute Myocardial Infarction: Real-World Findings from the Lombardy Health Database

Journal: Journal of Clinical Medicine 
Authors: Giancarlo Marenzi, Nicola Cosentino, Marta Resta, Claudia Lucci, Alice Bonomi, Filippo Trombara, Michele Della Rocca, Paolo Poggio, Olivia Leoni, Francesco Bortolan et al.

Impact of Prior Statin Therapy on In-Hospital Outcome of STEMI Patients Treated with Primary Percutaneous Coronary Intervention

Journal: Journal of Clinical Medicine 
Authors: Oreste Lanza, Nicola Cosentino, Claudia Lucci, Marta Resta, Mara Rubino, Valentina Milazzo, Monica De Metrio, Filippo Trombara, Jeness Campodonico, José Pablo Werba et al.

Mitochondrial Biomarkers in Patients with ST-Elevation Myocardial Infarction and Their Potential Prognostic Implications: A Prospective Observational Study

Journal: Journal of Clinical Medicine
Authors: Nicola Cosentino; Jeness Campodonico, Marco Moltrasio, Claudia Lucci, Valentina Milazzo, Mara Rubino, Monica De Metrio, Ivana Marana; Marco Grazi, Alice Bonomi et al.

Acute Kidney Injury in Diabetic Patients With Acute Myocardial Infarction: Role of Acute and Chronic Glycemia

Journal: Journal of the American Heart Association 
Authors: Giancarlo Marenzi, Nicola Cosentino, Valentina Milazzo, Monica De Metrio, Mara Rubino, Jeness Campodonico, Marco Moltrasio, Ivana Marana, Marco Grazi, Gianfranco Lauri et al.

Association Between Haptoglobin Phenotype and Microvascular Obstruction in Patients With ST-Segment Elevation Myocardial Infarction: A Cardiac Magnetic Resonance Study

Journal: JACC: Cardiovascular Imaging 
Authors: Gianluca Pontone, Daniele Andreini, Andrea I. Guaricci, Marco Guglielmo, Andrea Baggiano, Giuseppe Muscogiuri, Laura Fusini, Fabio Fazzari, Claudio Berzovini, Annalisa Pasquini et al.

Conclusion

Dr. Nicola Cosentino represents an exemplary candidate for recognition in the field of cardiology. His career is distinguished by a rare combination of clinical mastery, academic excellence, and innovative research. From his early achievements as a top graduate to his leadership roles in hospital cardiology units and industry, he has consistently demonstrated a vision to improve cardiovascular care through science and compassion. His research outputs have shaped understanding of acute coronary syndromes, myocardial remodeling, and multi-organ interactions, with direct implications for clinical practice and patient outcomes. Furthermore, his dedication to education, mentorship, and collaboration within international networks highlights his commitment to shaping the future of cardiovascular medicine. Through his pioneering research, impactful publications, and leadership contributions, Dr. Cosentino embodies the qualities of a transformative clinician-scientist. He stands as an ideal nominee for prestigious recognition, with a career that continues to inspire innovation and excellence in cardiovascular healthcare.

Carolina Watson | Healthcare experiences | Best Researcher Award

Published on by Invention Awards

🌟Prof Dr. Carolina Watson , Healthcare experiences, Best Researcher Award🏆

Professor at Universidad Autónoma de Barcelona, Spain

Dr. Dalia Ghanem is an established figure in the field of political science with a particular emphasis on Algerian politics, terrorism, and security in the Middle East and North Africa (MENA) region. Currently associated with the Malcolm H. Kerr Carnegie Middle East Center, her scholarly work delves into the dynamics of political violence, radicalization, and state-society relations.

Author Metrics

Scopus Profile

ORCID Profile

Dr. Ghanem’s publications are highly regarded in academic circles, contributing significantly to our understanding of contemporary political issues in Algeria and the broader MENA region. Her research articles and reports are frequently cited by peers, indicating her influence and the high regard in which her work is held.

  • Citations: Watson has 142 citations from 138 documents.
  • Publications: She has authored 15 documents.
  • h-index: Her h-index is 6. The h-index measures both the productivity and citation impact of the publications by a scholar.

Education

Dr. Ghanem earned her Ph.D. in Political Science from the University of Versailles-Saint-Quentin-en-Yvelines in France. Her academic background is complemented by extensive fieldwork and research in the MENA region, providing her with a robust theoretical and practical understanding of the subjects she explores.

Research Focus

Dr. Ghanem’s research primarily centers on the political and security issues in Algeria and the MENA region. She investigates the root causes and consequences of political violence, radicalization, and terrorism. Her work also explores state policies and their impact on society, particularly in the context of authoritarian regimes and social movements.

Professional Journey

Dr. Ghanem’s professional journey has been marked by her roles as a researcher and analyst at prestigious institutions. Before joining the Malcolm H. Kerr Carnegie Middle East Center, she worked at the French Institute for International and Strategic Affairs (IRIS) and contributed to various think tanks and academic institutions. Her career reflects a consistent dedication to understanding and addressing critical political and security challenges in the MENA region.

Honors & Awards

Dr. Ghanem has received numerous accolades for her contributions to political science and her insightful analysis of MENA region politics. These awards recognize her scholarly excellence, impactful research, and her role in influencing policy discussions and academic discourse on critical regional issues.

Publications Noted & Contributions

Dr. Ghanem has authored several influential publications, including research papers, policy briefs, and articles in esteemed journals. Her notable works include comprehensive analyses of the political landscape in Algeria, studies on terrorism and counterterrorism strategies, and explorations of the socio-political dynamics within authoritarian regimes. Her contributions have significantly shaped the understanding of these complex issues and provided valuable insights for policymakers and scholars alike.

Describing Non-Binary People’s Encounters with the Healthcare System: A Qualitative Study in Catalonia (Spain)

  • Journal: Archives of Sexual Behavior
  • Publication Date: May 2024
  • DOI: 10.1007/s10508-024-02849-x
  • Contributors: Rebeca Gómez-Ibáñez, Juan M. Leyva-Moral, Alexander Cruzado-Reyes, Lucas R. Platero, Nina Granel, Carolina E. Watson
  • Summary: This study explores the experiences of non-binary individuals within the healthcare system in Catalonia, highlighting the challenges and barriers they face.

Factors Contributing to Nurses’ Intention to Leave the Profession: A Qualitative Study in Catalonia, Spain, following the Latest Waves of COVID-19

  • Journal: Journal of Nursing Management
  • Publication Date: May 30, 2024
  • DOI: 10.1155/2024/7971020
  • Contributors: Carolina E. Watson, Maria Dolors Bernabeu-Tamayo, David Giménez-Díez, Manuel Lillo-Crespo, Juan M. Leyva-Moral, Abdulqadir Nashwan
  • Summary: This article examines the factors leading to nurses’ decisions to leave their profession post-COVID-19 in Catalonia, aiming to identify critical areas for intervention and support.

Exploring Adolescents’ Experiences of Continuing to Wear Face Masks during COVID‐19: A Qualitative Descriptive Study in Barcelona (Spain)

  • Journal: Health Expectations
  • Publication Date: April 2024
  • DOI: 10.1111/hex.14014
  • Contributors: Mariela Aguayo‐González, Juan M. Leyva‐Moral, David Giménez‐Diez, Andreu Colom‐Cadena, Isabel Martínez, Carolina Watson, Anna Bordas, Cinta Folch, Jordi Casabona
  • Summary: This study provides insights into adolescents’ perspectives and behaviors regarding the continued use of face masks during the COVID-19 pandemic in Barcelona.

Cultural Adaptation and Validation of the Caring Behaviors Assessment Tool into Spanish

  • Journal: BMC Nursing
  • Publication Date: April 10, 2024
  • DOI: 10.1186/s12912-024-01892-2
  • Contributors: Juan M. Leyva-Moral, Carolina Watson, Nina Granel, Cecilia Raij-Johansen, Ricardo A. Ayala
  • Summary: This research focuses on adapting and validating a tool to assess caring behaviors in nursing for Spanish-speaking populations, ensuring cultural relevance and accuracy.

Decoding Patient-Reported Measures (PRMs) Use in Clinical Practice: How and for What? The MATRICS Framework

  • Journal: Journal of Healthcare Quality Research
  • Publication Date: October 2023
  • DOI: 10.1016/j.jhqr.2023.09.005
  • Contributors: E. Gimenez, C. Watson, Y. Cossio-Gil
  • Summary: This article introduces the MATRICS framework to understand the application and objectives of patient-reported measures in clinical settings, aiming to enhance patient-centered care.

Research Timeline

Dr. Ghanem’s research trajectory has evolved over the years, beginning with her early work on political violence and radicalization. Over time, she has expanded her focus to include broader security issues and state-society relations in the MENA region. This evolution reflects her deepening expertise and her ability to adapt to emerging challenges and trends in her field of study.

Collaborations and Projects

Throughout her career, Dr. Ghanem has engaged in numerous collaborative projects with international organizations, academic institutions, and think tanks. These collaborations have enriched her research and extended its impact, allowing for a multidisciplinary approach to understanding and addressing the political and security issues in the MENA region. Her work often involves partnerships with other scholars, policymakers, and practitioners, fostering a collaborative environment for generating innovative solutions and advancing knowledge in her field.